Supporting this hypothesis, blood biomarker analyses in mild AD patients have revealed differential expressions of numerous inflammatory and redox-related genes, suggesting disruptions in NRF2 and NF-κB functions—both of which are major regulators of redox and inflammation homeostasis [85]. Here, NFKB1 is linked to Alzheimer disease.